2021-12156. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, Health and Human Services (HHS).

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control numberDate approval expires
    FDA recall regulations0910-02495/31/2024
    Premarket Notification for a New Dietary Ingredient0910-03305/31/2024
    Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring0910-04095/31/2024
    Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice0910-05635/31/2024
    Substances Prohibited From Use in Animal Food or Feed0910-06275/31/2024
    Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments0910-07825/31/2024
    Food Allergen Labeling and Reporting0910-07925/31/2024
    Study of Multiple Indications in Direct-to-Consumer Television Advertisements0910-08975/31/2024
    Start Signature

    Dated: June 4, 2021.

    Lauren K. Roth,

    Acting Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2021-12156 Filed 6-9-21; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
06/10/2021
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2021-12156
Pages:
30952-30952 (1 pages)
Docket Numbers:
Docket Nos. FDA-2014-N-1031, FDA-2013-N-0878, FDA-2014-N-0998, FDA-2014-N-1076, FDA-2013-N-0520, FDA-2017-N-6397, FDA-2014-N-1030, and FDA-2020-N-1228
PDF File:
2021-12156.pdf
Supporting Documents:
» Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
» Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
» Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities Submission for Office of Management and Budget Review Comment Request Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring
» Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring